---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-002339"
form_type: "8-K"
ticker: "CERO"
cik: "0001870404"
company_name: "CERO THERAPEUTICS HOLDINGS, INC."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:40:26.071982+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CERO Therapeutics issues 16.4M shares and warrants upon warrant exercise for $500K

## Summary
- Holder exercised 625 Preferred Warrants at $800/sh, paying $500K (20% OID on $625K stated value).
- Series A Preferred shares converted into 16,385,275 common shares of CERO.
- Company issued new warrants to purchase 16,385,275 common shares at $0.0582/sh (Jan 3 closing price).
- Proceeds included in previously reported cash balance as of Jan 7, 2025; exemption under Section 4(a)(2).

## SEC filing metadata
- accession: 0001213900-25-002339
- form_type: 8-K
- ticker: CERO
- cik: 0001870404
- company_name: CERO THERAPEUTICS HOLDINGS, INC.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/0001213900-25-002339-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870404/000121390025002339/ea0227335-8k_cerotherap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-002339
- JSON: https://secwatch.observer/filing/0001213900-25-002339.json
- Plain text: https://secwatch.observer/filing/0001213900-25-002339.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.